Retina/Vitreous News

The FDA has granted rare pediatric disease designation to an alpha-kinase 1 inhibitor to treat patients with retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis and headache, or ROSAH, syndrome.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye 2024, Sunir J. Garg, MD, FACS, FASRS, discusses 96-week data investigating aflibercept 8 mg for the treatment of neovascular age-related macular degeneration.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, David A. Eichenbaum, MD, discusses the potential for gene therapy to reduce the intravitreal injection treatment burden in retinal disease.

WAILEA, Hawaii — When making treatment decisions for geographic atrophy, atrophy geometry, lesion size and focality are some of the features that must be considered, according to a speaker here.

WAILEA, Hawaii — In this Healio video perspective from Retina 2024, Marion R. Munk, MD, PhD, overviews data investigating multiwavelength photobiomodulation for the treatment of dry age-related macular degeneration.

The first patient has been dosed in a phase 2 clinical trial investigating EYP-1901 for the treatment of diabetic macular edema, according to a press release from EyePoint Pharmaceuticals.

ROME — A deep learning algorithm developed at University of California, Los Angeles, showed superior performance compared with other algorithms and human graders in detecting early biomarkers of age-related macular degeneration progression.

NEW YORK — In a presentation at OSN New York, Shalesh Kaushal, MD, PhD, explains why he encourages ophthalmologists to consider using vitrectomy to treat vitreous floaters.

Healio’s top retina items last year included the FDA approvals of Syfovre for geographic atrophy and Eylea HD for wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.

Artificial intelligence has potential to facilitate accurate, frequent and larger-scale home monitoring of chronic ocular diseases when safely integrated into workflows, according to a review published in Current Opinion in Ophthalmology.